echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J Clin Oncol: An artificial intelligence model for breast cancer risk prediction based on mammography

    J Clin Oncol: An artificial intelligence model for breast cancer risk prediction based on mammography

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the latest data from the International Agency for Research on Cancer (IARC) in 2018, the incidence of breast cancer in female cancers worldwide is 24.
    2%, ranking first among female cancers, with 52.
    9% occurring in developing countries
    .


    Accurate risk assessment is critical to the success of breast cancer screening programs


    Breast cancer screening

    The risk model based on artificial intelligence (AI) has been proven, and compared with the current risk model used in clinical practice, it has made significant progress
    .


    However, the responsible deployment of new artificial intelligence requires careful verification among different groups of people


    The researchers collected screening mammograms and pathologically confirmed breast cancer results from different regions, and assessed the consistency index of Uno to Mirai to predict the risk of breast cancer within 1 to 5 years after mammography
    .

    The receiver operating curve of Mirai when selecting high-risk cohorts in some test sets

    The receiver operating curve of Mirai when selecting high-risk cohorts in some test sets

    A total of 128,793 mammograms of 62,185 individuals from 7 locations around the world were collected, of which 3815 individuals were diagnosed with breast cancer in the next 5 years
    .


    The consistency indexes obtained by Mirai in the 7 hospitals were 0.


    In summary, Mirai is a risk model based on mammography.
    It has maintained high accuracy in various test sets in 7 hospitals in 5 countries around the world
    .


    This is the most extensive verification of breast cancer models based on artificial intelligence so far, indicating that this technology can broadly improve the diagnosis and treatment of breast cancer


    Mirai is a risk model based on mammography.


    Original source:

    Adam Yala, et al.


    Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.